Kursinformation
Für dieses Unternehmen ist kein Kurs-Chart verfügbar.
()
Aktuelle News
News Funktionen
Weitere Funktionen
20 März 2015
07:05
Corporate
EN
Myriad Genetics, Inc.
Corporate
EN
Myriad Announces Prolaris(R) Test Biopsy Results From EMPATHY-P Study at European Association of Urology Annual Meeting
8 Januar 2015
06:05
Corporate
EN
Myriad Genetics, Inc.
Corporate
EN
Myriad Obtains CE Mark for Tumor BRACAnalysis CDx(TM) and Launches Test in Europe as Companion Diagnostic for PARP Inhibitors
24 Oktober 2014
15:17
Corporate
EN
Myriad Genetics, Inc.
Corporate
EN
Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in Europe
14 Mai 2014
13:05
Corporate
EN
Myriad Genetics, Inc.
Corporate
EN
Crescendo Bioscience’s Vectra(R) DA Predicts Radiographic Progression in Patients With Early Rheumatoid Arthritis
13:05
Corporate
EN
Myriad Genetics, Inc.
Corporate
EN
Crescendo Bioscience’s Vectra(R) DA Predicts Radiographic Progression in Patients With Early Rheumatoid Arthritis
7 April 2014
22:30
Corporate
EN
Myriad Genetics, Inc.
Corporate
EN
Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis(R)